Rita E. Serda, Ph.D.
Research Assistant Professor
Department of Internal Medicine, Division of Molecular Medicine
Department of Chemical & Biological Engineering
The University of New Mexico
Beyond the need for preventative vaccines, there is a global need for therapeutic cancer vaccines that are able to overcome cancer-related suppression of cell-mediated immune responses and guide specific immune responses against cells expressing tumor-associated neoantigens. Dr. Serda’s research projects include a unique cell processing method to transform cancer cells into stable, pathogen mimics, creating potent personalized cancer vaccines and optimization of Immunogenic nanoparticles loaded with cancer antigens and adjuvant and immunogenic cell death inducing chemotherapeutics and adjuvants.
ISSUED U.S. PATENTS (UNM-AFFILIATED)
10,881,612 Cationic Liposomes for Cancer Immunotherapy, issued January 5, 2021
PENDING U.S. PATENT APPLICATIONS (UNM-AFFILIATED)
Cationic Liposomes for Cancer Immunotherapy
Silicified Cell Replicas, Methods of Making, and Methods of Using
Liposomal Coated Nanoparticles for Immunotherapy Applications
A High Capacity Platform for Immunogenic Cancer Cell Death
Silicified Cell Replicas, Methods of Making, and Methods of Using
Silicified Immunogenic Cells , Methods of Making, and Methods of Using
Mesoporous Silica Nanoparticles, Methods of Making, and Methods of Using
Nanoparticle-Loaded Silicified Cells, Methods of Making, and Methods of Use
Silicified Tumor Cell Compositions and Methods
Additional technologies listing this individual as an inventor, may be found at the UNM Flintbox Researcher page. Each of the respective technologies will display updated patent and publication information.